About Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical is a publicly listed company based in Tosu (Japan) founded in 1834. Pharmaceuticals and over-the-counter medications are manufactured and distributed globally. Hisamitsu Pharmaceutical has completed 1 acquisition, including Noven. Its website hisamitsu.co.jp draws about 124 thousand monthly visits. Hisamitsu Pharmaceutical offers products and services including OTC Medications and Prescription Drugs. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Hisamitsu Pharmaceutical Co., Inc.
Company details
Manufacturer and distributor of pharmaceuticals and over-the-counter medications. The company develops and markets a diverse portfolio of products across various therapeutic areas. It also engages in research and development, focusing on innovative drug delivery systems. The organization maintains a strong commitment to corporate governance and sustainability initiatives. A significant portion of its business involves medical products, including those for pain relief and dermatological conditions. The company provides detailed information for healthcare professionals and patients on its products and their safe usage.
- Headquarters Tosu, Japan
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website hisamitsu.co.jp
- Social LinkedIn
- Legal Name Hisamitsu Pharmaceutical Co., Inc
- Investments & Acquisitions
Products & Services of Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical offers a comprehensive portfolio of products and services, including OTC Medications and Prescription Drugs.
Over-the-counter medications are manufactured for common ailments such as pain and skin conditions.
Prescription drugs are developed for specific treatments, including those related to neurological pain.
People of Hisamitsu Pharmaceutical
9 people are tracked at Hisamitsu Pharmaceutical (5 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Oscar Garcia | Sr. Director Of Sales Canada | Leadership |
Masanori Yokono | General Manager, Basic Research Laboratories, R&d Division | Leadership |
Kazuhide Nakatomi | President & CEO | Leadership |
Jim Lepis | President & CEO Hisamitsu America, Inc. Subsidiary Of Hisamitsu Pharmaceutical Co., Inc. | Leadership |
Clarence Wright Jr. | Chief Team Leader | Leadership |
Suzanne Schalk | Senior Brand Marketing Manager -salonpas | Team |
Jose Colon | Salonpas Brand Ambassador | Team |
Ogechi Sholadoye Acim | Marketing/ Brand Lead | Team |
Lisa Lawrence | Project Manager | Team |
Complete people profiles for Hisamitsu Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical is a publicly listed company on the TSE with ticker symbol 4530 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 Sep 1962
- Listed onTSE: 4530
- Listed entityHisamitsu Pharmaceutical Co., Inc.
- Exchange sectorHealth technology
Investments & Acquisitions by Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Noven.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A specialty pharmaceutical company focused on transdermal drug delivery. | noven.com | Miami, United States | 1987 | Jul 2009 | $430M |
Complete acquisition details for Hisamitsu Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Hisamitsu Pharmaceutical
3 dated milestones of Hisamitsu Pharmaceutical across 175 years, from founding to its latest funding, stage changes and deals.
- Founded Hisamitsu Pharmaceutical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Noven.
Web traffic of Hisamitsu Pharmaceutical
The website of Hisamitsu Pharmaceutical (hisamitsu.co.jp) receives about 124.4K visits a month and ranks #361,621 among all websites worldwide, #304 in Biotechnology and Pharmaceuticals.
- Monthly visits124.4K
▲ 11.2% vs previous month
- Unique visitors80.2K
per month
- Global rank#361,621
among all websites
- Category rank#304
Health · Biotechnology and Pharmaceuticals
- Bounce rate70%
- Pages per visit1.9
- Average visit56 sec
- DevicesDesktop 19% · Mobile 81%
Websites whose visitors overlap most with Hisamitsu Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
allegra.jp | allegra.jp | 100% | #375,557 | – | |
mikasaseiyaku.co.jp | mikasaseiyaku.co.jp | 94% | #1,369,730 | – | |
rubina.jp | rubina.jp | 94% | #1,905,178 | – | |
| ono.co.jp | 89% | #13,675,203 | View details | ||
hisamitsu-pharm.jp | hisamitsu-pharm.jp | 84% | #813,482 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Hisamitsu Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hisamitsu Pharmaceutical
Complete news archive for Hisamitsu Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical was founded in 1834.
Hisamitsu Pharmaceutical is headquartered in Tosu, Japan. It is registered at Tosu, Saga, Japan.
Manufacturer and distributor of pharmaceuticals and over-the-counter medications. The company develops and markets a diverse portfolio of products across various therapeutic areas. It also engages in research and development, focusing on innovative drug delivery systems. The organization maintains a strong commitment to corporate governance and sustainability initiatives. A significant portion of its business involves medical products, including those for pain relief and dermatological conditions. The company provides detailed information for healthcare professionals and patients on its products and their safe usage.
Hisamitsu Pharmaceutical offers OTC Medications and Prescription Drugs.
Yes, Hisamitsu Pharmaceutical is publicly traded on TSE under the ticker symbol 4530.
Hisamitsu Pharmaceutical has made 1 acquisition, including Noven.
Hisamitsu Pharmaceutical operates through Hisamitsu Pharmaceutical Co., Inc.
The website of Hisamitsu Pharmaceutical receives about 124 thousand visits a month and ranks #361,621 among all websites worldwide.